GlassScriptPhysician profile
Donald M Whiting
NPI 1194710608
$3,198.90
in general payments reported to CMS, 2019-2025
11 companies · $2,146 in 2025
The $2,146 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $214 · 2021: $77.92 · 2022: $53.92 · 2023: $165 · 2024: $215 · 2025: $2,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,594 · Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,593.55 |
| Food and Beverage | $933.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,837.17 | 2025 | Mazor X System, Unid_pass, Stealthstation S8 Platform |
| Boston Scientific Corporation | $406.34 | 2019-2025 | General - Pain Management, General - Dbs |
| Stryker Corporation | $372.31 | 2020-2023 | Spinemap |
| Retropsoas Technologies, LLC | $215.33 | 2024 | |
| Carl Zeiss Meditec, INC. | $182.99 | 2019 | |
| Medtronic USA, INC. | $111.81 | 2020 | |
| Depuy Synthes Sales INC. | $26.88 | 2021 | |
| Surgalign Spine Technologies, INC. | $26.05 | 2019 | |
| Integra Lifesciences Corporation | $20.02 | 2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Whiting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.